1. The use of iodine-125 for interstitial implants. DHEW Publication 76–8022;Hilaris,1975
2. Nuclear Regulatory Commission. 10CFR35.75: Release of individuals containing unsealed byproduct material or implants containing byproduct material. Code of Federal Regulations, Title 10, Volume 1, Revised as of January, 2001. Washington, DC: U.S. Government Printing Office.
3. Precautions in the management of patients who have received therapeutic amounts of radionuclides. Report No. 37;National Council on Radiation Protection and Measurements,1970
4. Transperineal iodine-125 seed implantation in prostatic cancer guided by transrectal ultrasonography;Holm;J Urol,1983
5. Transperineal percutaneous iodine-125 implantation for prostatic carcinoma using transrectal ultrasound and template guidance;Blasko;Endocuriether Hyperthermia Oncol,1987